Sirona Biochem CEO: Unique Opportunity for Global Success in the Cosmetic and Therapeutic Spaces

TL;DR

Sirona Biochem, a cosmetic ingredient and drug discovery company, has achieved significant milestones, including clinical trials for a diabetic drug and a successful launch of a cosmetic ingredient. The company's unique platform technology and focus on improving carbohydrate molecules have attracted interest from major cosmetic and pharmaceutical companies.

Transcript

welcome to inn ceo talks joining me today is dr howard veraco the ceo and chair of the board of serona biochem which trades on the tsx venture under the symbol sbm on the otc under the symbol srbcf and on the frankfurt under the symbol zsb sirona biochem is a cosmetic ingredient and drug discovery company with a proprietary platform technology sero... Read More

Key Insights

• 💁 Sirona Biochem was formed in 2009 as a licensing agreement and later acquired a chemistry company, becoming a full biotech company specializing in carbohydrate stabilization.
• 🚀 The company has achieved significant milestones, including a clinical trial for a diabetic drug and a successful launch of a cosmetic ingredient for treating dark spots.
• 🤑 Sirona Biochem's platform technology allows them to create and patent new compounds from existing ones, opening opportunities in multiple fields.
• 🍉 The company focuses on both cosmetics and therapeutics, with cosmetics providing a shorter path to commercialization and therapeutics offering long-term rewards.
• 🧍 Sirona Biochem's skincare product stands out in the market due to its safety and effectiveness, addressing the issue of toxicity associated with many existing products.
• 💦 The company has licensed its cosmetic ingredient to a large cosmetic company and is currently working on a licensing deal with a top global pharmaceutical company.
• 📽️ Sirona Biochem's pipeline includes multiple ongoing projects, attracting interest from potential partners and investors.

Questions & Answers

Q: What is Sirona Biochem's focus and expertise?

Sirona Biochem specializes in stabilizing carbohydrate molecules to improve their efficiency and safety in the cosmetic and therapeutic fields. Their unique platform technology has enabled them to develop innovative compounds.

Q: What are Sirona Biochem's major achievements to date?

The company has successfully completed a clinical trial for a new diabetic drug, reaching phase one, in collaboration with Wah-Bong Pharmaceuticals. They have also launched a cosmetic ingredient for treating dark spots, which has undergone two successful clinical trials and is commercially available.

Q: How does Sirona Biochem manage research in different fields simultaneously?

Sirona Biochem's scientists use their platform technology to improve existing molecules in various fields. By enhancing compound efficacy, reducing toxicity, and creating new compounds, the company can address different areas such as cosmetics and therapeutics.

Q: Can you elaborate on Sirona Biochem's cosmetic ingredient for lightening skin and treating wrinkles?

Sirona Biochem has developed a skin lightening compound that effectively evens out skin tone and treats dark spots. Unlike other products on the market, it is both safe and effective, offering a breakthrough solution for consumers with dark spots or uneven skin tone.

Summary & Key Takeaways

• Sirona Biochem is a biotech company that specializes in stabilizing carbohydrate molecules to improve their efficiency and safety in the cosmetic and therapeutic fields.

• The company has successfully completed a clinical trial for a diabetic drug in partnership with Wah-Bong Pharmaceuticals and launched a cosmetic ingredient for treating dark spots in collaboration with Rodan and Fields.

• Sirona Biochem's pipeline includes multiple ongoing projects in various stages of development, attracting interest from major cosmetic and pharmaceutical companies.